Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022
Lindh, Erika; Smura, Teemu; Blomqvist, Soile; Liitsola, Kirsi; Vauhkonen, Hanna; Savolainen, Laura; Ikonen, Jaana; Ronkainen, Jukka; Taskila, Jyri; Sakaranaho, Pertti; Savolainen-Kopra, Carita; Vapalahti, Olli; Ikonen, Niina (2022-04-21)
Lindh Erika, Smura Teemu, Blomqvist Soile, Liitsola Kirsi, Vauhkonen Hanna, Savolainen Laura, Ikonen Jaana, Ronkainen Jukka, Taskila Jyri, Taskila Tea, Sakaranaho Pertti, Savolainen-Kopra Carita, Vapalahti Olli, Ikonen Niina. Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022. Euro Surveill. 2022;27(16):pii=2200257. https://doi.org/10.2807/1560-7917.ES.2022.27.16.2200257
© The Author(s) 2022. This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence and indicate if changes were made.
https://creativecommons.org/licenses/by/4.0/
https://urn.fi/URN:NBN:fi-fe2022092660185
Tiivistelmä
Abstract
Recombinant sequences of the SARS-CoV-2 Omicron variant were detected in surveillance samples collected in north-western Finland in January 2022. We detected 191 samples with an identical genome arrangement in weeks 3 to 11, indicating sustained community transmission. The recombinant lineage has a 5’-end of BA.1, a recombination breakpoint between orf1a and orf1b (nucleotide position 13,296–15,240) and a 3’-end of BA.2 including the S gene. We describe the available genomic and epidemiological data about this currently circulating recombinant XJ lineage.
Kokoelmat
- Avoin saatavuus [34545]
